Stock data
Korsana Biosciences, Inc. (KRSA)
Korsana Biosciences, Inc. (KRSA) reported revenue of US$2.07M and net income of -US$3.53M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$2.07M | — | -US$4.97M | -US$3.53M | — |
| 2024 | US$2.00M | — | -US$3.63M | -US$3.06M | — |
| 2023 | US$0.00M | — | -US$12.95M | -US$5.26M | — |
| 2022 | US$0.30M | — | -US$18.54M | -US$44.08M | — |
| 2021 | US$3.94M | — | -US$55.20M | -US$51.65M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$1.75M | — |
| 2026-03-31 | US$0.00M | -US$3.18M | — |
| 2025-12-31 | US$1.02M | -US$0.80M | — |
| 2025-09-30 | US$0.88M | -US$0.98M | — |
| 2025-06-30 | US$0.09M | -US$0.32M | — |
| 2025-03-31 | US$0.08M | -US$1.43M | — |
| 2024-12-31 | US$1.81M | US$0.53M | — |
| 2024-09-30 | US$0.19M | -US$0.72M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.